Tag:Tilray

Europe

European Round-Up: France’s CESE Calls For End To ‘Bitter Failure’ Of Cannabis Prohibition, Clever Leaves and Tilray Slash Portuguese Operations, & More From Czechia...

FRANCE’s Economic, Social and Environmental Council (CESE) has released a ‘draft opinion’ calling for the legalisation of cannabis. On Tuesday, January 24, 2023, during a...

Ben Stevens - January 26, 2023

Press Releases

Tilray’s Medical Cannabis Product Now Available And Reimbursed Under Ireland’s Medical Cannabis Access Program

PRESS RELEASE TILRAY Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring and empowering the worldwide community to...

BusinessCann - October 5, 2022

News

As North American Investment In EU Cannabis Industry Tops $600m, Companies Are Gearing Up For The ‘Next Wave’ Of Capital Influx

Read our latest interview with Casa Verde's Managing Partner, Karan Wadhera, about the opportunities Europe presents for overseas investors. NORTH American cannabis operators have invested...

Ben Stevens - April 7, 2022

Analysis

EU Cannabis Stocks Review: How Ukraine Crisis Is Impacting Cannabis Stocks, Chill Brands’ Revenue Could Be $1m Less & More From Tilray and MGC...

LAST week began with a number of European cannabis stocks levelling out following dramatic declines days earlier in reaction to Russia’s invasion of Ukraine. While...

Ben Stevens - March 7, 2022

Latest news

NewsMarch 17, 2023

European Cannabis Stocks Review: Celadon Shares Spike 150% On Licence Update, OCT Continues Recovery, & Creso Pharma Censured By ASX

Celadon Pharmaceuticals Celadon Pharmaceuticals stock has skyrocketed by more than 150% this week following the announcement that its current Home...

- Advertisement -

NewsMarch 16, 2023

Benefits of F1 Cannabis Hybrids from Royal Queen Seeds

F1 hybrids have revolutionised the way we grow and use plants. Now, F1 cannabis seeds are bringing growers, smokers,...

Press ReleasesMarch 15, 2023

Celadon Pharmaceuticals Announces Home Office Approval Of Licence For Commercial Sale Of GMP Cannabis

PRESS RELEASE FURTHER to the announcement dated 16 January 2023, Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on...

Must read

NewsMarch 17, 2023

European Cannabis Stocks Review: Celadon Shares Spike 150% On Licence Update, OCT Continues Recovery, & Creso Pharma Censured By ASX

Celadon Pharmaceuticals Celadon Pharmaceuticals stock has skyrocketed by more than...

Medicinal CannabisMarch 15, 2023

Proposed Changes To Germany’s Medical Cannabis Framework Would ‘Seriously Impact Both Patients And Industry’ If Brought In Tomorrow

TOMORROW, Germany’s Federal Joint Committee (G-BA) is expected to...

Tag:Tilray

Latest news

European Cannabis Stocks Review: Celadon Shares Spike 150% On Licence Update, OCT Continues Recovery, & Creso Pharma Censured By ASX

Benefits of F1 Cannabis Hybrids from Royal Queen Seeds

Celadon Pharmaceuticals Announces Home Office Approval Of Licence For Commercial Sale Of GMP Cannabis

Must read

European Cannabis Stocks Review: Celadon Shares Spike 150% On Licence Update, OCT Continues Recovery, & Creso Pharma Censured By ASX

Proposed Changes To Germany’s Medical Cannabis Framework Would ‘Seriously Impact Both Patients And Industry’ If Brought In Tomorrow

Editor Picks

Huge Stride For UK Medicinal Cannabis With £12m Plan To Cultivate 300,000 Plants A Year

Amazon Enters CBD Retail Market – But Only In One Country

New ‘Cannabis Initiative’ From ‘Secretive’ UN Body May Cause Serious Harm To Global Industry

Must Read

Can CBD Be Sold As ‘Hemp Oil’ To Avoid Novel Food Rules?

Legal UK Cannabis Industry Mapped Out For First Time – And Poised For Rapid Change

Europe’s CBD U-Turn Set To Cause Widespread Harm To Businesses And Consumers

BusinessCann

About BusinessCann

Follow Us